Re:Treat Medicines Like Netflix Treats Shows
by refurb on Thursday March 07, 2019 @11:24AM
(#19329304)
The reason why Gilead is doing this is because their hepatitis C franchise has already slowed and will likely be much smaller in a few years. Far better to negotiate a deal like this and lock a country into buying your treatment than to lose market share against competitors.
[ Parent
| on HN ]
There are no comments on this comment yet.